Expression of immune checkpoint molecules and activation markers in T cells from chronic lymphocytic leukemia (CL) patients

被引：0
|
作者：
Palma, M. [1 ,2 ]
Gentilcore, G. [2 ]
Mozaffari, F. [2 ]
Heimersson, K. [2 ]
Nasman-Glaser, B. [2 ]
Hansson, L. [1 ,2 ]
Osterborg, A. [1 ,2 ]
Mellstedt, H. [2 ]
机构：
[1] Karolinska Univ Hosp, Hematol, Stockholm, Sweden
[2] Karolinska Inst, Oncol Pathol, Stockholm, Sweden
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
21
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [31] Thalidomide (T) influences antigen expression on tumor cells from chronic lymphocytic leukemia.
    Venugopal, P
    Sivaraman, S
    Gladstone, B
    Jajeh, A
    Huang, XK
    Brien, TO
    ODonnell, K
    Gregory, S
    Preisler, H
    BLOOD, 2000, 96 (11) : 232B - 232B
  • [32] Increased Expression of CD69 on T Cells as an Early Immune Marker for Human Cytomegalovirus Reactivation in Chronic Lymphocytic Leukemia Patients
    Petersen, Charlotte C.
    Nederby, Line
    Roug, Anne S.
    Skovbo, Anni
    Peterslund, Niels A.
    Hokland, Peter
    Nielsen, Bendt
    Hokland, Marianne
    VIRAL IMMUNOLOGY, 2011, 24 (02) : 165 - 169
  • [33] Regulatory T cells in chronic lymphocytic leukemia
    Aref, Salah
    Elkhodary, Tawfik
    Azmy, Emad
    Hakim, Hazem
    El Menshawy, Nadia
    Ebrahim, Lamiaa
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2014, 39 (02): : 68 - 71
  • [34] Regulatory T cells in chronic lymphocytic leukemia
    Aref S.
    Azmy E.
    Hakim H.
    El Khodary T.
    El Menshawy N.
    Ebrahim L.
    Comparative Clinical Pathology, 2015, 24 (3) : 649 - 652
  • [35] RESIDUAL T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
    GOLDSTONE, AH
    KERR, L
    URBANIAK, SJ
    FARMER, A
    IRVINE, WJ
    LANCET, 1973, 1 (7801): : 481 - 482
  • [36] T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
    KAY, NE
    DOUGLAS, SD
    ESTREN, S
    LANCET, 1974, 2 (7892): : 1326 - 1326
  • [37] Expression of multiple immune checkpoint molecules on T cells in malignant ascites from epithelial ovarian carcinoma
    Imai, Yuichi
    Hasegawa, Kosei
    Matsushita, Hirokazu
    Fujieda, Nao
    Sato, Sho
    Miyagi, Etsuko
    Kakimi, Kazuhiro
    Fujiwara, Keiichi
    ONCOLOGY LETTERS, 2018, 15 (05) : 6457 - 6468
  • [38] Checkpoint Blockade in Melanoma Patients With Underlying Chronic Lymphocytic Leukemia
    Smithy, James W.
    Pianko, Matthew J.
    Maher, Colleen
    Postow, Michael A.
    Shoushtari, Alexander N.
    Momtaz, Parisa
    Chapman, Paul B.
    Wolchok, Jedd D.
    Park, Jae H.
    Callahan, Margaret K.
    JOURNAL OF IMMUNOTHERAPY, 2021, 44 (01) : 9 - 15
  • [39] Impact of Protein Kinase C Activation and Monoclonal Antibodies on Immune Checkpoint Regulation and B Cell Function in Patients with Chronic Lymphocytic Leukemia
    Ntsethe, Aviwe
    Dludla, Phiwayinkosi Vusi
    Nkambule, Bongani Brian
    BIOMEDICINES, 2025, 13 (03)
  • [40] Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation
    Scrivener, S
    Kaminski, ER
    Demaine, A
    Prentice, AG
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (04) : 959 - 964
12345